Contribution of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms to Negative Symptoms in Schizophrenia-Reference-Cited by-同舟云学术

Contribution of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms to Negative Symptoms in Schizophrenia

Published:2008-01 Issue:1 Volume:63 Page:42-48
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Roffman Joshua L.,Weiss Anthony P.,Purcell Shaun,Caffalette Christopher A.,Freudenreich Oliver,Henderson David C.,Bottiglieri Teodoro,Wong Donna H.,Halsted Charles H.,Goff Donald C.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference51 articles.

1. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation;Abdolmaleky;Am J Med Genet B Neuropsychiatr Genet,2004

2. Nutrition and depression: focus on folate;Alpert;Nutrition,2000

3. Methylenetetrahydrofolate reductase variant and schizophrenia/depression;Arinami;Am J Med Genet,1997

4. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain;Bertolino;J Neurosci,2006

5. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia;Bertolino;Am J Psychiatry,2004

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Rare variants in the MTRR gene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia;Frontiers in Psychiatry;2024-07-12

2. Association between MTHFR (677C>T and 1298A>C) polymorphisms and psychiatric disorder: A meta-analysis;PLOS ONE;2022-07-14

3. The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review;Biomedicine & Pharmacotherapy;2022-02

4. The association of serum folate levels with schizophrenia symptoms;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022

5. Early-Onset Schizophrenia: A Special Phenotype of the Disease Characterized by Increased MTHFR Polymorphisms and Aggravating Symptoms;Neuropsychiatric Disease and Treatment;2021-08